ACH
VRTX icon

ArrowMark Colorado Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History

ArrowMark Colorado Holdings’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,688
Closed -$1.96M – 347
2019
Q2 		$1.96M Hold
10,688
– – 0.02% 245
2019
Q1 		$1.97M Hold
10,688
– – 0.02% 245
2018
Q4 		$1.77M Hold
10,688
– – 0.02% 271
2018
Q3 		$2.06M Hold
10,688
– – 0.02% 281
2018
Q2 		$1.82M Sell
10,688
-562
-5% -$87.1K 0.02% 276
2018
Q1 		$1.83M Hold
11,250
– – 0.02% 259
2017
Q4 		$1.69M Sell
11,250
-810
-7% -$120K 0.02% 267
2017
Q3 		$1.83M Sell
12,060
-690
-5% -$104K 0.02% 260
2017
Q2 		$1.64M Buy
12,750
+2,500
+24% +$301K 0.02% 256
2017
Q1 		$1.12M Buy
10,250
+5,000
+95% +$440K 0.02% 250
2016
Q4 		$387K Buy
5,250
+1,364
+35% +$111K 0.01% 277
2016
Q3 		$339K Hold
3,886
– – 0.01% 270
2016
Q2 		$334K Hold
3,886
– – 0.01% 261
2016
Q1 		$309K Sell
3,886
-764
-16% -$69.1K 0.01% 253
2015
Q4 		$585K Hold
4,650
– – 0.02% 244
2015
Q3 		$484K Buy
4,650
+158
+4% +$20.3K 0.01% 258
2015
Q2 		$555K Buy
+4,492
New +$566K 0.01% 265
2014
Q3 		– Sell
-18,158
Closed -$1.72M – 322
2014
Q2 		$1.72M Sell
18,158
-8,520
-32% -$597K 0.05% 188
2014
Q1 		$1.89M Sell
26,678
-2,372
-8% -$188K 0.06% 180
2013
Q4 		$2.16M Buy
29,050
+4
+0% +$279 0.07% 176
2013
Q3 		$2.2M Hold
29,046
– – 0.07% 178
2013
Q2 		$2.33M Buy
+29,046
New +$2.14M 0.63% 46

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

ArrowMark Colorado Holdings's VRTX Position: Q3 2019 in Review

ArrowMark Colorado Holdings sold out of Vertex Pharmaceuticals (VRTX) in Q3 2019, closing a stake of 10,688 shares — an estimated $1.96M sold.

ArrowMark Colorado Holdings first reported a position in VRTX in Q2 2013 and held it in 22 quarters. The position peaked at $2.33M in Q2 2013. 708 funds tracked by Wall St. Rank hold VRTX as of Q3 2019.

  • ArrowMark Colorado Holdings reported no remaining Vertex Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 10,688 Vertex Pharmaceuticals shares in Q3 2019, an estimated $1.96M.
  • ArrowMark Colorado Holdings first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 22 quarters.
  • ArrowMark Colorado Holdings's Vertex Pharmaceuticals position peaked at $2.33M in Q2 2013.
  • 708 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2019.

Based on ArrowMark Colorado Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.